Who is the new president Lu Kong-Ming?

Lu Kong-Ming has served as Chairman of the Investment Review Committee and is deeply experienced in strategic investment decisions.

Was this leadership change sudden?

Labeled as a 'job adjustment,' this appears to be a planned transition rather than an abrupt change.

What will former President Wu You-Mei do next?

No official statement on her next role, but she may assume a different position within the company.

What are the company's main investment areas?

The company focuses on next-gen healthcare, including cancer therapy, regenerative medicine, and AI diagnostics.

Will this affect investors?

The company emphasizes continuity, indicating no immediate changes to investment strategy.

AI News NQ Analysis

[Diamond Investment] Announcement of Change in Company President

NQ Score 77/100

N1 Content Completeness 9

AI Summary (NQ-processed)

Diamond Biotech Investment Co., Ltd. announced on July 3, 2026, a change in its President due to a management reshuffle, with Mr. Lu Kong-Ming succeeding Ms. Wu You-Mei as the new President.

AI Analysis

Frequently Asked Questions

Q: Who is the new president Lu Kong-Ming?: A: Lu Kong-Ming has served as Chairman of the Investment Review Committee and is deeply experienced in strategic investment decisions.
Q: Was this leadership change sudden?: A: Labeled as a 'job adjustment,' this appears to be a planned transition rather than an abrupt change.
Q: What will former President Wu You-Mei do next?: A: No official statement on her next role, but she may assume a different position within the company.
Q: What are the company's main investment areas?: A: The company focuses on next-gen healthcare, including cancer therapy, regenerative medicine, and AI diagnostics.
Q: Will this affect investors?: A: The company emphasizes continuity, indicating no immediate changes to investment strategy.